𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiation-Induced Changes of Telomerase Activity in a Human Ewing Xenograft Tumor

✍ Scribed by Andreas Schuck; Christopher Poremba; Claudia Lanvers; Stefan Könemann; Tobias Schleifer; Daniel Wai; Kirsten Horn; Stefan Hesselmann; Yvonne Braun; Bernd Frodermann; Karl-Ludwig Schäfer; Raihanatou I. Diallo; Claudia E. Rübe; Christian Rübe; Barbara Dockhorn-Dworniczak; Normann Willich

Book ID
105776051
Publisher
Springer
Year
2002
Tongue
German
Weight
606 KB
Volume
178
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of radiation-induced regrowt
Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model
✍ Marion A. Joschko; Lorraine K. Webster; Janice Groves; Kally Yuen; Manuela Palat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Gemcitabine, a cytidine nucleoside analogue, has schedule-dependent antitumor activity in vitro and in vivo. Gemcitabine also has dose-and time-dependent radiosensitization properties in vitro. Thus it may have therapeutic application in combination with radiation. The aims of this study were to inv

Attenuation of telomerase activity by ha
Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells
✍ Marie Yeo; Sung Young Rha; Hei Cheul Jeung; Shen Xiong Hu; Sang Hwa Yang; Yang S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 322 KB

## Abstract Ribozyme possesses specific endoribonuclease activity and catalyzes the hydrolysis of specific phosphodiester bonds, which results in the cleavage of target RNA sequences. Here, we evaluated the ability of hammerhead ribozymes targeting human telomerase RNA (hTR) to inhibit the catalyti

Anti-tumor activity of a combination of
Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model
✍ Renate R.J. de Groot-Besseling; Theo J.M. Ruers; Annemieke A. van Kraats; Geert 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 151 KB

## Abstract Angiostatin, a proteolytic fragment of plasminogen consisting of the first 3 or 4 kringle domains, reduces tumor growth by specifically inhibiting tumor angiogenesis. Angiostatin is generated __in vitro__ in a 2‐step process. First, plasminogen is converted to plasmin by plasminogen act